Catalyst Pharmaceuticals, Inc. Share Price Deutsche Boerse AG
Stocks
CN2
US14888U1016
Pharmaceuticals
|
Market Closed -
Deutsche Boerse AG
07:00:58 14/07/2026 BST
|
5-day change | 1st Jan Change | ||
| 27.30 EUR | +2.63% |
|
-.--% | +35.01% |
| 08-03 | CDP targets new defense acquisitions after T-Defence deal - sources | RE |
| 08-03 | CDP's new chapter, a push for global companies | AN |
| Market Cap | 3.85B 3.33B 3.13B 2.85B 5.35B 369B 5.44B 36.66B 14.33B 185B 14.47B 14.16B 613B | P/E 2024 |
15.9x | P/E 2025 | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 3.15B 2.72B 2.56B 2.32B 4.37B 301B 4.44B 29.94B 11.71B 151B 11.82B 11.56B 501B | EV / Sales 2024 |
4.02x | EV / Sales 2025 | 3.67x |
| Free-Float |
99.94% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Catalyst Pharmaceuticals, Inc.
| 1 day | +2.63% | ||
| 3 months | +4.20% | ||
| 6 months | +39.50% | ||
| Current year | +35.01% |
| Current year | 18.96 |  | 27.4 |
| 1 year | 16.15 | | 27.4 |
| 3 years | 10.93 | | 27.4 |
| 5 years | 4.12 | | 27.4 |
| 10 years | 0.66 | | 27.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Daly
CEO | Chief Executive Officer | 65 | 31/12/2023 |
Michael Kalb
DFI | Director of Finance/CFO | 55 | 31/12/2023 |
William Andrews
CTO | Chief Tech/Sci/R&D Officer | 62 | 31/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 48 | 14/07/2026 | |
Massimo Marin
BRD | Director/Board Member | - | 14/07/2026 |
Enrica Dogali
BRD | Director/Board Member | - | 14/07/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.63% | -.--% | - | - | 3.85B | |
| -0.31% | +2.44% | +41.97% | -0.61% | 80.23B | |
| -1.02% | -0.51% | -2.54% | +26.80% | 50.69B | |
| -3.10% | -4.84% | +9.26% | +158.46% | 46.87B | |
| -0.74% | +3.26% | -49.46% | -48.10% | 46.34B | |
| -0.39% | +0.91% | +55.50% | -23.07% | 31B | |
| -0.52% | +7.01% | +137.24% | -36.68% | 25.28B | |
| -0.30% | -0.33% | +39.46% | +84.18% | 24.36B | |
| -1.42% | -1.11% | -2.29% | +189.51% | 20.81B | |
| -1.83% | -2.82% | +61.91% | +105.60% | 16.08B | |
| Average | -0.70% | +1.44% | +32.34% | +50.68% | 37.96B | |
| Weighted average by Cap. | -0.98% | +1.13% | +24.82% | +36.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 492M 425M 399M 363M 682M 47.02B 694M 4.68B 1.83B 23.55B 1.85B 1.81B 78.25B | 589M 509M 478M 435M 817M 56.32B 831M 5.6B 2.19B 28.2B 2.21B 2.16B 93.72B |
| Net income | 164M 142M 133M 121M 227M 15.67B 231M 1.56B 609M 7.85B 615M 602M 26.08B | 214M 185M 174M 158M 297M 20.49B 302M 2.04B 797M 10.26B 805M 787M 34.11B |
| Net Debt | -514M -444M -417M -380M -714M -49.18B -726M -4.89B -1.91B -24.63B -1.93B -1.89B -81.85B | -706M -610M -573M -521M -980M -67.55B -996M -6.72B -2.63B -33.82B -2.65B -2.59B -112B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CPRX Stock
- CN2 Stock
Select your edition
All financial news and data tailored to specific country editions
